Key Details
Price
$3.30Annual ROE
-102.40%Beta
0.18Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 22, 2023Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain officers and directors of the Company participated in the offering for aggregate subscriptions of approximately $1.26 million.
DETROIT, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the pricing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain officers and directors of the Company are participating in the offering for aggregate subscriptions of approximately $1.26 million. The offering is expected to close on January 8, 2025, subject to the satisfaction of customary closing conditions.
DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a “best efforts” underwritten public offering. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Company to Discuss Growth for NurseMagic™ for both B2C and B2B Users in 50 States and 21 Countries, Representing 87 Professions Company to Discuss Growth for NurseMagic™ for both B2C and B2B Users in 50 States and 21 Countries, Representing 87 Professions
Presentation Includes Discussion of Monetization of NurseMagic™ DETROIT, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today it will release an end of year video shareholder update to its website today, December 23, 2024 at 3:00 pm ET. The presentation will be available to shareholders here: https://ir.amesite.com/news-events/media.
Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare
Company Generating Recurring Revenue in $330 Billion Revenue Home Health and Home Care Industries Company Generating Recurring Revenue in $330 Billion Revenue Home Health and Home Care Industries
33,000 Home Care Target Market Represents Significant Revenue Potential 33,000 Home Care Target Market Represents Significant Revenue Potential
DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the Lesher Foundation's Newsmakers: 24/25 Season on October 24, 2024, following Former U.S. Representative Liz Cheney, Former World #1 Tennis Player and Founder of Chris Evert Charities, Chris Evert, Host of CNN's Smerconish and Best-Selling Author, Michael Smerconish and other eminent thinkers and experts.
FAQ
- What is the ticker symbol for Amesite?
- Does Amesite pay dividends?
- What sector is Amesite in?
- What industry is Amesite in?
- What country is Amesite based in?
- When did Amesite go public?
- Is Amesite in the S&P 500?
- Is Amesite in the NASDAQ 100?
- Is Amesite in the Dow Jones?
- When was Amesite's last earnings report?
- When does Amesite report earnings?
- Should I buy Amesite stock now?